Skip to main content

Table 1 Use of antithrombotic drugs, beta-blockers and statins among men and women.

From: Equity in the use of antithrombotic drugs, beta-blockers and statins among Finnish coronary patients

  

All three drugs

Antithrombotics

Betablockers

Statins

n

  

Men

Women

Men

Women

Men

Women

Men

Women

Men

Women

 

Total

51.6

49.1

93.3

89.1

81.8

80.6

62.1

58.6

1429

1221

Age (years)

45–54

59.6

45.2

95.0

85.0

86.2

77.4

69.3

52.7

218

93

 

55–64

54.4

46.0

94.1

87.6

82.5

79.8

65.8

55.0

594

411

 

65–74

46.2

51.3

91.9

90.5

79.6

81.5

56.1

61.4

617

717

Income third

highest

55.4

48.0

93.7

89.4

81.8

80.3

68.2

55.1

519

303

 

intermed

48.6

51.9

94.4

89.0

82.3

81.7

58.7

61.9

456

366

 

lowest

50.0

50.1

92.0

89.0

81.8

80.9

57.3

60.1

353

468

MI

no

47.9

47.1

91.7

87.5

79.6

79.2

58.9

56.7

792

916

 

yes

55.3

57.2

95.5

95.1

85.1

85.1

64.5

66.4

613

276

Use of

less

51.0

48.4

93.3

89.1

81.9

81.0

61.4

57.8

1211

953

nitrates

≥ 1/week

52.9

53.4

92.6

90.2

82.6

79.4

61.4

62.5

194

246

Chest pain

no

51.8

46.5

94.1

88.5

80.0

78.3

63.6

57.0

738

391

 

yes

51.6

50.8

93.1

89.6

84.2

81.7

60.5

60.1

623

758

Diabetes

no

51.3

48.6

92.9

89.0

81.1

80.8

61.9

58.3

1232

1056

 

yes

49.9

54.2

95.0

91.0

86.9

81.1

57.7

62.9

197

165

Heart

no

51.7

49.6

93.4

89.4

82.0

80.7

62.4

59.3

1129

962

failure

yes

48.9

48.6

92.3

89.1

81.5

81.3

57.3

57.6

300

259

Revascularisation

no

41.7

40.9

90.5

86.4

80.3

77.9

51.4

51.1

738

891

 

yes

61.7

72.9

96.0

97.2

83.8

88.4

72.4

80.4

683

322

  1. Age group specific and age-standardised prevalence percentages by income, disease history and severity, and comorbidities.